Browse > Article
http://dx.doi.org/10.3345/kjp.2009.52.1.61

Drug resistance of Mycobacterium tuberculosis in children  

Lee, Soo Jin (Departments of Pediatrics, College of Medicine, Eulji University)
Ahn, Young Min (Departments of Pediatrics, College of Medicine, Eulji University)
Kim, Hee Jin (Department of Epidemiology, The Korean Institute of Tuberculosis)
Publication Information
Clinical and Experimental Pediatrics / v.52, no.1, 2009 , pp. 61-67 More about this Journal
Abstract
Purpose : The rate of drug-resistant tuberculosis (DR-TB) in children is an indicator of the effectiveness of TB control programs in the community. This study aimed to assess the prevalence of DR-TB in children and evaluate TB management. Methods : Between January 1999 and July 2007, drug susceptibility tests for anti-TB drugs were employed for patients aged less than 19 years with culture-positive TB. Results : A total of 607 cases (16.6%) were resistant to at least one anti-TB drug as follows: isoniazid (INH; 13.8%), rifampin (8.9%), pyrazinamide (4.2%), streptomycin (3.7%), ethambutol (EMB; 5.9%), and para-aminosalicylic acid (PAS; 1.9%). Multidrug-resistant (MDR) TB was found in 276 cases (7.6%); extensive drug resistant (XDR) TB, in 5 cases (0.2%). The rate of resistance to at least one anti-TB drug in children aged >15 years (16.1%) was significantly lower than that in children aged <15 years (20.5%) (P=0.016). The rate of resistance to at least one anti-TB drug and multidrug-resistance in this survey decreased significantly (P<0.001) as compared to the previous survey (1987-1995). The rate of resistance to INH, EMB, and PAS also significantly decreased (P<0.05). Conclusion : The rate of DR-TB in children in Korea has decreased over time; however, it remains higher than that in other countries. MDR-TB and XDR-TB are the emerging problems in Korean children. Therefore, the selection of effective drugs through drug susceptibility tests and evaluating risk factors of resistant TB is essential to successful therapy and a decreased incidence of DR-TB.
Keywords
Tuberculosis; Drug-resistant; Multidrug-resistant tuberculosis; Children;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kim SJ, Bai GH, Hong YP. Drug resistance of Mycobacterium tuberculosis in Korea. Int J Tuberc Lung Dis 1997;1: 302-8   ScienceOn
2 World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. WHO/HTM/TB/ 2006.361. Geneva, Switzerland: WHO; 2006
3 Jang SH, Cha YH, Ahn YM, Kim SJ. Drug-resistant tuberculosis in children. J Korean Pediatr Soc 1997;40:818-24
4 Pablos-Mendez A, Raviglione MC, Laszlo A, Binkin N, Rieder HL, Bustreo F, et al. Global surveillance for antituberculosis-drug resistance, 1994-1997. N Engl J Med 1998;338: 1641-9   DOI   PUBMED   ScienceOn
5 Torun T, Gungor G, Ozmen I, Bolukbasi Y, Maden E, Bicakci B, et al. Side effects associated with the treatment of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2005;9:1373-7
6 Raviglione MC, Smith IM. XDR tuberculosis implications for global public health. N Engl J Med 2007;356:656-9   DOI   ScienceOn
7 Wane LG. Simple pyrazinamidase and urease tests for routine identification of mycobacteria. Am Rev Respir Dis 1974; 109:147-51
8 Korean Academy of Tuberculosis and Respiratory Diseases. Guideline for the management of pulmonary tuberculosis. Seoul: Korean Academy of Tuberculosis and Respiratory Diseases; 2005
9 Starke J. Tuberculosis in children. Prim Care 1996;23:861-81   DOI   ScienceOn
10 Bai GH, Park YK, Choi YW, Bai JI, Kim HJ, Chang CL, et al. Trend of anti-tuberculosis drug resistance in Korea, 1994-2004. Int J Tuberc Lung Dis 2007;11:571-6   ScienceOn
11 World Health Organization. Global map and information on XDR-TB [internet]. Geneva, Switzerland: WHO; 2007 [cited 2007 Dec 31]. Available from: http://www.who.int/tb/challenges/xdr/xdrmap_oct07_en.pdf
12 American Thoracic Society/Center for Disease Control and Prevention. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000;161:1376-95   PUBMED   ScienceOn
13 Kwon KB, Park JY, Yoon BY, Kim MR, Lee HJ, Kim EJ, et al. The significance of bacteriologic examination in the childhood tuberculosis. J Korean Pediatr Soc 1994;37:221-9
14 Nelson LJ, Schneider E, Wells CD, Moore M. Epidemiology of childhood tuberculosis in the united states, 19932001: The need for continued vgilance. Pediatrics 2004;114:333-41   DOI   PUBMED   ScienceOn
15 Kim SJ, Hong YP, Han YC, Kim SJ. Drug resistance of Mycobacterium tuberculosis in Korea. Tuberculosis Respir Dis 1991:38;99-107   DOI   ScienceOn
16 Centers for Disease Control and Prevention (CDC). Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drug-worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 2006;55:301-5   ScienceOn
17 World Health Organization. Global tuberculosis control: suveillance, planning, financing. WHO/HTM/TB 2006. 362. Geneva, Switzerland: WHO; 2006
18 Nelson LJ, Wells CD. Global epidemiology of childhood tuberculosis. Int J Tuberc Lung Dis 2004;8:636-47   ScienceOn
19 Ena J, Valls V. Short-course therapy with rifampin plus isoniazid compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis. Clin Infect Dis 2005;40:670-6   DOI   ScienceOn
20 Zignol M, Hosseini MS, Wright A, Weezenbeek CL, Nunn P, Watt CJ, et al. Global incidence of multidrug-resistant tuberculosis. J Infect Dis 2006;194:479-85   DOI   ScienceOn
21 Schaaf HS, Marias BJ, Hesseling AC, Gie RP, Beyers N, Donald PR. Childhood drug-resistant tuberculosis in the Western Cape Province of South Africa. Acta Paediatrica 2006;95:523-8   DOI   ScienceOn
22 Ormerod LP. Rifampicin and isoniazid prophylactic chemotherapy for tuberculosis. Arch Dis Child 1998;78:169-71   DOI   PUBMED
23 Park YK, Park YS, Bai JY, Kim HJ, Lew WJ, Chang CH, et al. Primary drug resistance rate of the private sector in 2003-2005. Tuberc Respir Dis 2008;64:87-94   DOI   ScienceOn
24 Mukherjee JS, Rich ML, Socci AR, Joseph JK, Viru FA, Shin SS, et al. Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet 2004;363:474-81   DOI   ScienceOn
25 Dye C, Espinal MA, Watt CJ, Mbiaga C, Williams BG. Worldwide incidence of multidrug-resistant tuberculosis. J Infect Dis 2002;185:1197-202   DOI   ScienceOn
26 Bai GH. Anti-tuberculosis drug resistance in Korea. CDMR 2005;16:101-7
27 de Pontual L, Balu L, Ovetchkine P, Maury-Tisseron B, Lachassinne E, Cruaud P, et al. Tuberculosis in adolescents: A French retrospective study of 52 cases. Pediatr Infect Dis J 2006;25:930-2   DOI   ScienceOn
28 Schaaf HS, Gie RP, Kennedy M, Beyers N, Hesseling PB, Donald PR. Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30- month follow-up. Pediatrics 2002;109:765-71   DOI   ScienceOn
29 British Thoracic Association. A controlled trial of six months chemotherapy in pulmonary tuberculosis: first report: results during chemotherapy. Br J Dis Chest 1981;75:141-53   DOI   ScienceOn
30 World Health Organization. Anti-tuberculosis drug resistance in the world: 3rd Report: the WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance 1999-2002 Geneva, Switzerland: WHO; 2004
31 Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003;163:1009-21   DOI   ScienceOn
32 Centers for Disease Control and Prevention. Revised definition of extensively drug-resistant tuberculosis. MMWR 2006;55:1176
33 Steiner M, Cosio A. Primary tuberculosis in children : I. Incidence of primary drug resistant disease in 332 children observed between the years 1961 and 1964 at the Kings Country Medical Center of Brooklyn. N Engl J Med 1966; 274:755-9   DOI   PUBMED   ScienceOn
34 Ganetti G, Fox W, Khmenko A, Mahler HT, Menon NK, Mitchison DA, Rist N, Smelev NA. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull Wld Hlth Org 1969;41:21-43   PUBMED   ScienceOn
35 Aziz MA, Wright A, Laszlo A, De Muynck A, Portaels F, Van Deun A, et al. Epidemiology of anti-tuberculosis drug resistance (the global project on anti-tuberculosis drug resistance surveillance): an updated analysis. Lancet 2006;368: 2142-54   DOI   ScienceOn
36 Choi JC, Lim SY, Suh GY, Chung MP, Kim HJ, Kwon OJ, et al. Drug resistance rates of Mycobacterium tuberculosis at a private referral center in Korea. J Korean Med Sci 2007;22:677-81   DOI   ScienceOn
37 Hesseling A, Schaaf H, Gie R, Starke J, Beyers N. A critical review of diagnostic approaches used in the diagnosis of childhood tuberculosis. Int J Tuberc Lung Dis 2002;6:1038- 45   ScienceOn